Flex Pharma, Inc. (NASDAQ: FLKS) Starts Presentation at 29th Annual ROTH Conference
Flex Pharma (NASDAQ: FLKS) is a biotechnology company focused on developing innovative and proprietary treatments for cramps and spasms associated with the severe neurological diseases of ALS, MS and peripheral neuropathies such as Charcot-Marie-Tooth (CMT). Flex Pharma was founded by National Academy of Science members Rod MacKinnon, M.D. (2003 Nobel Laureate), and Bruce Bean, Ph.D., recognized leaders in the fields of ion channels and neurobiology, along with Chair and CEO Christoph Westphal, M.D., Ph.D. For more information, visit the company’s website at www.flex-pharma.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and a full array of…







